Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Genetic analysis of aquaporin-4 in neuromyelitis optica.

Matiello M, Schaefer-Klein JL, Hebrink DD, Kingsbury DJ, Atkinson EJ, Weinshenker BG; NMO Genetics Collaborators.

Neurology. 2011 Sep 20;77(12):1149-55. doi: 10.1212/WNL.0b013e31822f045b. Epub 2011 Sep 7.

PMID:
21900637
2.

Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression.

Kantarci OH, Hebrink DD, Schaefer-Klein J, Sun Y, Achenbach S, Atkinson EJ, Heggarty S, Cotleur AC, de Andrade M, Vandenbroeck K, Pelfrey CM, Weinshenker BG.

Arch Neurol. 2008 Mar;65(3):349-57. doi: 10.1001/archneurol.2007.66.

PMID:
18332247
3.

CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.

Kantarci OH, Morales Y, Ziemer PA, Hebrink DD, Mahad DJ, Atkinson EJ, Achenbach SJ, De Andrade M, Mack M, Ransohoff RM, Lassmann H, Bruck W, Weinshenker BG, Lucchinetti CF.

J Neuroimmunol. 2005 Dec;169(1-2):137-43. Epub 2005 Sep 22.

PMID:
16182378
4.

IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis.

Kantarci OH, Goris A, Hebrink DD, Heggarty S, Cunningham S, Alloza I, Atkinson EJ, de Andrade M, McMurray CT, Graham CA, Hawkins SA, Billiau A, Dubois B, Weinshenker BG, Vandenbroeck K.

Genes Immun. 2005 Mar;6(2):153-61.

PMID:
15674394
5.

Association of APOE polymorphisms with disease severity in MS is limited to women.

Kantarci OH, Hebrink DD, Achenbach SJ, Pittock SJ, Altintas A, Schaefer-Klein JL, Atkinson EJ, De Andrade M, McMurray CT, Rodriguez M, Weinshenker BG.

Neurology. 2004 Mar 9;62(5):811-4.

PMID:
15007140
6.

CD95 polymorphisms are associated with susceptibility to MS in women. A population-based study of CD95 and CD95L in MS.

Kantarci OH, Hebrink DD, Achenbach SJ, Atkinson EJ, de Andrade M, McMurray CT, Weinshenker BG.

J Neuroimmunol. 2004 Jan;146(1-2):162-70.

PMID:
14698859
7.

A population-based study of IL4 polymorphisms in multiple sclerosis.

Kantarci OH, Schaefer-Klein JL, Hebrink DD, Achenbach SJ, Atkinson EJ, McMurray CT, Weinshenker BG.

J Neuroimmunol. 2003 Apr;137(1-2):134-9.

PMID:
12667657
8.

CTLA4 is associated with susceptibility to multiple sclerosis.

Kantarci OH, Hebrink DD, Achenbach SJ, Atkinson EJ, Waliszewska A, Buckle G, McMurray CT, de Andrade M, Hafler DA, Weinshenker BG.

J Neuroimmunol. 2003 Jan;134(1-2):133-41.

PMID:
12507781
9.

Myeloperoxidase -463 (G-->A) polymorphism associated with lower risk of lung cancer.

Kantarci OH, Lesnick TG, Yang P, Meyer RL, Hebrink DD, McMurray CT, Weinshenker BG.

Mayo Clin Proc. 2002 Jan;77(1):17-22.

PMID:
11794452
10.

Association of a tumor necrosis factor alpha polymorphism with MS susceptibility.

Weinshenker BG, Hebrink DD, Atkinson E, Kantarci OH.

Neurology. 2001 Oct 9;57(7):1341-2. No abstract available.

PMID:
11591866
11.

Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis.

Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG.

J Neuroimmunol. 2000 Jul 1;106(1-2):220-7.

PMID:
10814801
12.

Association of a myeloperoxidase promoter polymorphism with multiple sclerosis.

Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG.

J Neuroimmunol. 2000 Jun 26;105(2):189-94.

PMID:
10742562
13.

Genetic variation in the B7-1 gene in patients with multiple sclerosis.

Weinshenker BG, Hebrink DD, Klein C, Atkinson EJ, O'Brien PC, McMurray CT.

J Neuroimmunol. 2000 Jun 26;105(2):184-8.

PMID:
10742561
14.

DNA compression caused by an upstream point mutation.

Weinshenker BG, Hebrink DD, Gacy AM, McMurray CT.

Biotechniques. 1998 Jul;25(1):68-72.

Supplemental Content

Loading ...
Support Center